Literature DB >> 6487496

Interaction of isoxicam with acetylsalicylic acid.

M Esquivel, F Cussenot, R I Ogilvie, D S East, D H Shaw.   

Abstract

Ten healthy male volunteers were given 200 mg p.o. of isoxicam after an overnight fast and the plasma concentrations over time followed for 96 h by h.p.l.c. Five days later enteric coated acetylsalicylic acid (ASA) 650 mg four times daily was started and continued for 10 days producing steady state trough plasma salicylate of 83 mg/l (range 21-133). A second 200 mg isoxicam dose was given 5 days after starting ASA and the plasma concentration time-curve again followed. After ASA, there was no change in lag time (0.54 vs 0.51 h), time to peak concentration (10 vs 10 h), or disappearance t1/2 (28.7 vs 31.0 h) however the peak isoxicam concentration and AUC were reduced 18 and 22% respectively (P less than 0.01). Plasma protein binding of isoxicam studied by equilibrium dialysis was 96 +/- 1% in the absence and 86 +/- 5% in the presence of ASA. The reduction in binding was unrelated to plasma SA concentrations achieved or observed reductions in AUC for plasma isoxicam. ASA decreased plasma isoxicam binding, peak plasma isoxicam concentrations and AUC without altering the apparent disappearance half-life of total plasma isoxicam after a single oral dose.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6487496      PMCID: PMC1463616          DOI: 10.1111/j.1365-2125.1984.tb02505.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  11 in total

1.  The aspirin-ibuprofen interaction in rheumatoid arthritis.

Authors:  D M Grennan; D G Ferry; M E Ashworth; R E Kenny; M Mackinnon
Journal:  Br J Clin Pharmacol       Date:  1979-11       Impact factor: 4.335

2.  Interactions of aspirin with nonsteroidal antiinflammatory drugs in man.

Authors:  A Rubin; B E Rodda; P Warrick; C M Gruber; A S Ridolfo
Journal:  Arthritis Rheum       Date:  1973 Sep-Oct

3.  The effect of aspirin on serum indomethacin.

Authors:  G D Champion; H E Paulus; E Mongan; R Okun; C M Pearson
Journal:  Clin Pharmacol Ther       Date:  1972 Mar-Apr       Impact factor: 6.875

4.  Naproxen-aspirin interactions in man.

Authors:  E J Segre; M Chaplin; E Forchielli; R Runkel; H Sevelius
Journal:  Clin Pharmacol Ther       Date:  1974-04       Impact factor: 6.875

5.  Interaction between aspirin and indomethacin in the treatment of rheumatoid arthritis.

Authors:  R Jeremy; J Towson
Journal:  Med J Aust       Date:  1970-07-18       Impact factor: 7.738

6.  Indomethacin--aspirin interaction: a clinical appraisal.

Authors:  P M Brooks; J J Walker; M A Bell; W W Buchanan; A R Rhymer
Journal:  Br Med J       Date:  1975-07-12

7.  Combination therapy with naproxen and aspirin in rheumatoid arthritis.

Authors:  R F Willkens; E J Segre
Journal:  Arthritis Rheum       Date:  1976 Jul-Aug

8.  Ketoprofen-aspirin interactions.

Authors:  R L Williams; R A Upton; J N Buskin; R M Jones
Journal:  Clin Pharmacol Ther       Date:  1981-08       Impact factor: 6.875

9.  Piroxicam pharmacokinetics in man: aspirin and antacid interaction studies.

Authors:  D C Hobbs; T M Twomey
Journal:  J Clin Pharmacol       Date:  1979 May-Jun       Impact factor: 3.126

10.  Diclofenac sodium (Voltarol): drug interactions and special studies.

Authors:  P D Fowler
Journal:  Rheumatol Rehabil       Date:  1979
View more
  7 in total

Review 1.  Pharmacokinetic drug interactions with nonsteroidal anti-inflammatory drugs.

Authors:  R K Verbeeck
Journal:  Clin Pharmacokinet       Date:  1990-07       Impact factor: 6.447

Review 2.  Drug interactions involving aspirin (acetylsalicylic acid) and salicylic acid.

Authors:  J O Miners
Journal:  Clin Pharmacokinet       Date:  1989-11       Impact factor: 6.447

3.  Pharmacokinetics of isoxicam in hepatic disease.

Authors:  N Ferry; G Cuisinaud; D Ouzan; C Trepo; J Sassard
Journal:  Br J Clin Pharmacol       Date:  1986       Impact factor: 4.335

4.  The effect of concurrent aspirin upon plasma concentrations of tenoxicam.

Authors:  R O Day; P D Paull; S Lam; B R Swanson; K M Williams; D N Wade
Journal:  Br J Clin Pharmacol       Date:  1988-10       Impact factor: 4.335

Review 5.  Salicylate intoxication in the elderly. Recognition and recommendations on how to prevent it.

Authors:  C Durnas; B J Cusack
Journal:  Drugs Aging       Date:  1992 Jan-Feb       Impact factor: 3.923

Review 6.  Pharmacokinetics of oxicam nonsteroidal anti-inflammatory agents.

Authors:  K T Olkkola; A V Brunetto; M J Mattila
Journal:  Clin Pharmacokinet       Date:  1994-02       Impact factor: 6.447

Review 7.  Pharmacokinetic-pharmacodynamic drug interactions with nonsteroidal anti-inflammatory drugs.

Authors:  J R Brouwers; P A de Smet
Journal:  Clin Pharmacokinet       Date:  1994-12       Impact factor: 6.447

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.